- 401. Leurocristine Sulfate
- [The sulfate salt of a naturally occurring vinca alkaloid. Vincristine binds to and stabilizes tubulin, thereby interrupting tubulin polymerization and preventing the formation of the mitotic spindle and cell division; treated cells are unable to undergo mitosis and are arrested in metaphase. This agent also disrupts macromolecular synthesis. (NCI04) ( NCI )] (UMLS (NCI) C0042680) =Organic Chemical; Pharmacologic Substance ;
=22-Oxovincaleukoblastine;
=VINCRISTINE SULFATE 1 MG/ML | - 418. LEVOBETAXOLOL HYDROCHLORIDE
- [The hydrochloride salt form of levobetaxolol, the S-isomer of the -selective beta-1 adrenergic receptor antagonist betaxolol with anti-glaucoma activity and devoid of intrinsic sympathomimetic activity. When applied topically in the eye, levobetaxolol reduces aqueous humor secretion and lowers the intraocular pressure (IOP). ( NCI )] (UMLS (NCI) C0876234) =Organic Chemical; Pharmacologic Substance ;
|
- 402. Leustatin
- (UMLS (NCI) C0701346) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 419. LEVOBUNOLOL
- [A naphthalenone and non-cardioselective adrenergic beta-receptor antagonist with anti-glaucoma activity. Upon administration in the eye, levobunolol blocks beta-adrenergic receptors, thereby causing vasoconstriction. Levobunolol also decreases ciliary's body production of aqueous humor, leading to a decrease in aqueous humor. ( NCI )] (UMLS (NCI) C0006388) =Organic Chemical; Pharmacologic Substance =Propanolamines;
[OP101] BETA-BLOCKERS, TOPICAL OPHTHALMIC =LEVOBUNOLOL HYDROCHLORIDE;
|
- 403. leuvectin
- [An agent that delivers the gene for interleukin-2 (IL-2) into cells to increase production of IL-2 by the cells. ( NCI )] (UMLS (NCI) C0677671) =Organic Chemical; Pharmacologic Substance ;
| - 420. LEVOCABASTINE
- [A synthetic piperidine derivative with antihistamine properties. Levocabastine is a second generation histamine-1 receptor antagonist. When applied locally into the eye as a topical solution, this agent reduces itching, rhinorrhea and symptoms of allergic rhinitis or conjunctivitis. ( NCI )] (UMLS (NCI) C0064870) =Organic Chemical; Pharmacologic Substance ;
=Piperidines;
[OP900] OPHTHALMICS, OTHER =4-Piperidinecarboxylic Acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, Monohydrochloride,(-)-(1(cis)3alpha,4beta)-;
|
- 404. LEV/TMX
- (UMLS (NCI) C0281023) =Therapeutic or Preventive Procedure
| - 421. LEVOCETIRIZINE
- (UMLS (NCI) C1174893) =Organic Chemical; Pharmacologic Substance ;
|
- 405. LEVALLORPHAN
- [An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683) ( MSH )] (UMLS (NCI) C0023554) =Organic Chemical; Pharmacologic Substance
| - 422. levofloxacin
- [A substance used to treat bacterial infections. It belongs to the family of drugs called quinolone antibiotics. ( NCI )] (UMLS (NCI) C0282386) =Organic Chemical; Antibiotic ;
=ofloxacin;
[AM900] ANTI-INFECTIVES, OTHER;
[OP201] ANTIBACTERIALS, TOPICAL OPHTHALMIC;
=LEVOFLOXACIN 25 MG/ML;
LEVOFLOXACIN 250 MG;
LEVOFLOXACIN 5 MG/ML;
LEVOFLOXACIN 500 MG;
LEVOFLOXACIN 750 MG;
LEVOFLOXACIN 0.5 % |
- 406. Levallorphan Tartrate
- (UMLS (NCI) C0770439) =Organic Chemical; Pharmacologic Substance
| - 423. Levomenthol
- [A levo isomer of menthol, an organic compound made synthetically or obtained from peppermint or mint oils with flavoring and local anesthetic properties. When added to pharmaceuticals and foods, menthol functions as a fortifier for peppermint flavors. It also has a counterirritant effect on skin and mucous membranes, thereby, producing a local analgesic or anesthetic effect. ( NCI )] (UMLS (NCI) C0771655) =Organic Chemical; Pharmacologic Substance
|
- 407. Levator Ani
- (UMLS (NCI) C0224384) =Body Part, Organ, or Organ Component
| - 424. Levomepromazine Maleate
- (UMLS (NCI) C0607673) =Organic Chemical; Pharmacologic Substance
|
- 408. LEVATOR MUSC SUSPENSION
- (UMLS (ICD9CM) C0194512) =Therapeutic or Preventive Procedure
| - 425. Levonantradol
- [A synthetic cannabinoid analogue of delta (9)-tetrahydrocannabinol (delta(9)-THC) with antiemetic and anti-analgesic properties. Although its precise mechanism of action is unknown, levonantradol appears to bind and activate the cannabinoid receptors CB1 and/or CB2. (NCI04) ( NCI )] (UMLS (NCI) C0125660) =Organic Chemical; Pharmacologic Substance ;
|
- 409. Levator Palpebrae Superioris
- (UMLS (NCI) C0224134) =Body Part, Organ, or Organ Component
| - 426. levopa
- [ ] (UMLS (CSP) C0700880) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine
|
- 410. Level 1 skin repair.
- (UMLS (HL7) C1547505) =Intellectual Product =Ambulatory Payment Classification Code;
| - 427. LEVORPHANOL
- [A synthetic derivative of morphine with analgesic activities. Levorphanol mimics the actions of morphine, however, it is about 8 times more potent than morphine. This agent binds to opioid mu receptors, thereby producing analgesia, euphoria, sedation, respiratory depression, miosis, bradycardia and physical dependence. ( NCI )] (UMLS (NCI) C0023586) =Organic Chemical; Pharmacologic Substance =[CN101] OPIOID ANALGESICS;
morphinan =dextromethorphan;
2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, Tartrate;
|
- 411. Level of Care
- (UMLS (HL7) C1547668) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Intensive care;
Critical care;
Routine;
Surgery;
Ambulatory;
Emergency;
Isolation;
| - 428. LEVOXADROL
- (UMLS (NCI) C0125663) =Organic Chemical; Pharmacologic Substance ;
|
- 412. Level of care
- (UMLS (HL7) C1548572) =Intellectual Product =Location characteristic ID;
| - 429. Lewis Y Antigen
- [A carbohydrate molecule expressed on the surface of solid tumors including lung, intestinal, breast, prostate, pancreatic, esophageal, stomach, colon, rectal or ovarian cancers. ( NCI )] (UMLS (NCI) C0298751) =Carbohydrate; Immunologic Factor
|
- 413. Level of Evidence
- [A formal ranking system of the strength of evidence linked to a reported result. ( NCI )] (UMLS (NCI) C0393009) =Finding
| - 430. Lewy body
- [filamentous cytoplasmic inclusions of unknown pathogenesis in some brain areas; found in association with several disabling and dementing neurodegenerative disorders. ( CSP )] (UMLS (CSP) C0085200) =Cell Component ;
=cellular inclusions;
|
- 414. Levelock Village
- (UMLS (HL7) C1550910) =Population Group =NativeEntityAlaska;
| - 431. Lexapro
- [Trade name of escitalopram, the active S-enantiomer of the racemic citalopram. ( MSH )] (UMLS (NCI) C1170371) =Organic Chemical; Pharmacologic Substance ;
|
- 415. Leviviridae
- [A family of bacteriophages that infects enterobacteria, CAULOBACTER, and PSEUDOMONAS. The genome consists of linear, positive-sense single-stranded RNA. ( MSH )] (UMLS (CSP) C0206388) =Virus
| - 432. Lexiva
- (UMLS (NCI) C1320129) =Organophosphorus Compound; Pharmacologic Substance ;
|
- 416. Levo-Dromoran
- (UMLS (NCI) C1450007) =Organic Chemical; Pharmacologic Substance
| - 433. Leydig Cell Neoplasm of Ovary
- (UMLS (NCI) C1335164) Leydig Cell Neoplasm of the Ovary;
Leydig Cell Tumor of Ovary;
Leydig Cell Tumor of the Ovary;
Ovarian Leydig Cell Neoplasm;
Ovarian Leydig Cell Tumor;
Ovarian Leydig Cell Tumor, not Otherwise Specified =Neoplastic Process |
- 417. LEVOBETAXOLOL
- [The S-isomer of betaxolol, a selective beta-1 adrenergic receptor antagonist with anti-glaucoma activity and devoid of intrinsic sympathomimetic activity. When applied topically in the eye, levobetaxolol reduces aqueous humor secretion and lowers the intraocular pressure (IOP). ( NCI )] (UMLS (NCI) C1171274) =Organic Chemical; Pharmacologic Substance ;
| - 434. Leydig Cell Neoplasm of Testis
- (UMLS (NCI) C0863027) Leydig Cell Neoplasm of the Testis;
Leydig Cell Tumor of Testis;
Leydig Cell Tumor of the Testis;
Testicular Leydig Cell Neoplasm;
Testicular Leydig Cell Tumor =Neoplastic Process |
home
